The presence of both K and O antigens of Klebsiella aerogenes was found necessary to protect the organism from either complement-mediated serum killing or phagocytosis in the absence of specific antisera. Optimal phagocytic ingestion of K. aerogenes NCTC 5055 could be achieved in the presence of either anti-K or anti-O sera or to a much smaller extent in antisera raised against a rough unencapsulated mutant (M10B) derived from NCTC 5055. Anti-O sera failed to opsonize a clinical klebsiella isolate (DL1) possessing immunologically identical lipopolysac-charide, but did so when the amount of capsule was physically reduced. The serum sensitivity of the encapsulated strains was unaffected by the addition of specific antisera. Fresh serum was bacteriostatic for an unencapsulated smooth mutant (M10) derived from NCTC 5055. This bacteriostatic effect was reduced by heat-inactivation of the serum or by the addition of anti-O serum. M10 was rendered sensitive to the bactericidal action of serum in the presence of antisera raised against M10B or after chelation with MgEGTA to isolate alternative complement pathway activity. The rough unencapsulated mutant (M10B) was rapidly killed by fresh serum, an effect which could be delayed by chelation with MgEGTA. The serum sensitivity of M10B was unaffected by the presence of anti-M10B sera. Thus, the O antigen, unlike the K antigen, of these klebsiella strains is not antiphagocytic but it does confer some protection against the rapid bactericidal activity of serum complement.
BraudeA.I.,
DouglasH.,
DavisC.E.1973; Treatment and prevention of intravascular coagulation with antiserum to endotoxin. Journal of Infectious Diseases 128:S157–164
CrowleyJ.P.,
ZinnerS.H.,
PeterG.1982; Opsonisation of serum sensitive and serum resistant E. coli by rough mutant (Re) antisera. Journal of Laboratory and Clinical Medicine 90:197–205
EhrenworthL.,
BaerH.1956; The pathogenicity of K. pneumoniae for mice - the relationship to the quantity and rate of production of type- specific capsular polysaccharide. Journal of Bacteriology 72:713–717
FinchJ.E.,
BrownM.R.W.1978; The effect of growth environment on the killing of Pseudomonas aeruginosa by rabbit polymorphonuclear leucocytes and by cationic proteins. Infection and Immunity 20:340–346
FineD.P.,
MarneyS.R.,
ColleyD.G.,
SergentJ.S.,
Des-PrezR.M.1972; C3 shunt activation in human serum chelated with EGTA. Journal of Immunology 109:807–809
GuttmanR.M.,
WaibronB.A.1975; Bactericidal blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection. Clinical and Experimental Immunology 19:121–130
HowardC.J.,
GlynA.A.1971; The virulence for mice of strains of E. coli related to the effect of their K antigens on their resistance to phagocytosis and killing by complement. Immunology 20:767–777
IharaI.,
HaradaY.,
IharaS.,
KawakamiM.1982; A new complement-dependent bactericidal factor found in non-immune mouse sera: specific binding to polysaccharide of Ra chemotype Salmonella. Journal of Immunology 128:1256–1260
MccabeW.R.1972; Immunisation with R mutants of S. minnesota. I. Protection against challenge with heterologous Gram-negative bacilli. Journal of Immunology 108:601–610
PowellD.A.1979; Structure, solution properties and biological interactions of some microbial extracellular polysaccharides. In Microbial Polysaccharides and Polysaccharases pp. 117–160BerkeleyR.C.W.,
GoodayG.W.,
EllwoodD.C.
Edited by London: Academic Press for the Society for General Microbiology;
PoxtonI.R.,
SutherlandI.W.1976; Isolation of rough mutants of Klebsiella aerogenes and their synthesis of polysaccharides. Journal of General Microbiology 96:195–202
RobbinsJ.B.,
SchneersonR.,
EganW.B.,
VannW.,
LiuD.T.1980; Virulence properties of bacterial capsular polysaccharides - unanswered questions. In The Molecular Basis of Microbial Pathogenicity the report of the Dahlem Workshop on The Molecular Basis of the Infective Process pp. 115–132SmithH.,
SkehelJ.J.,
TurnerM.J.
Edited by Weinheim: Verlag Chemie;
StendahlO.,
NormanB.,
EdeboL.1979; Influence of O and K antigens on the surface properties of E. coli in relation to phagocytosis. Acta pathologica et microbiologica scandinavica B87:85–91
TaylorP.W.,
MessnerP.,
PartonR.1981; Effect of growth environment on cell envelope components of E. coli in relation to human serum sensitivity. Journal of Medical Microbiology 14:9–20
TraubW.H.1981; Failure of a commercial, intravenously applicable IgG(ab2) preparation (Gamma-venin) to enhance human serum bactericidal activity against Serratia marcescens. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene(Abteilung I Originale A) 249:504–511
Van DijkC.,
VerbrughH.A.,
Van Erne-Van DertolM.E.,
PetersR.,
VerhoefJ.1981; Escherichia coli antibodies in opsonisation and protection against infection. Journal of Medical Microbiology 14:381–389
WestphalO.,
JannK.1965; Bacterial lipopoly-saccharides: extraction with phenol/water and further applications of the procedure. Methods in Carbohydrate Chemistry583–91WhistlerR.L.
Edited by New York: Academic Press;
YoungL.S.,
StevensP.,
IngramJ.1975; Functional role of antibody against core glycolipid of Enterobacteriaceae. Journal of Clinical Investigation 56:850–861
ZieglerE.J.,
MccutchanJ.A.,
BraudeA.I.1978; Clinical trials of core glycolipid in Gramnegative bacteraemia. Transactions of the Association of American Physicians 91:253–258